New approaches to drug delivery through the blood-brain barrier

Brightman, 1977, Exp. Eye Res., 25, 1, 10.1016/S0014-4835(77)80008-0 Pardridge, 1991 Fishman, 1987, J. Neurosci. Res., 18, 299, 10.1002/jnr.490180206 Broadwell, 1988, 85, 632 Davson, 1987 Aird, 1984, Exp. Neurol., 86, 342, 10.1016/0014-4886(84)90192-4 Neuwelt, 1984, 43, 214 Gennuso, 1993, Cancer Invest., 11, 118, 10.3109/07357909309024829 Cornford, 1992, Cancer Res., 52, 138 Pardridge, 1993, J. Clin. Invest., 92, 2224, 10.1172/JCI116825 Baba, 1991, J. Cereb. Blood Flow Metab., 11, 638, 10.1038/jcbfm.1991.115 Inamura, T. and Black, K. L. J. Cereb. Blood Flow Metab. (in press) Nagy, 1985, Acta Neuropathol., 68, 160, 10.1007/BF00688639 Salahuddin, 1988, Acta Neuropathol., 76, 1, 10.1007/BF00687674 Oldendorf, 1993, 90, 307 Levin, 1980, J. Med. Chem., 23, 682, 10.1021/jm00180a022 Trauble, 1971, J. Membrane Biol., 4, 193, 10.1007/BF02431971 Schackert, 1989, Selective Cancer Ther., 5, 73, 10.1089/sct.1989.5.73 Oldendorf, 1971, Am. J. Physiol., 221, 1629, 10.1152/ajplegacy.1971.221.6.1629 Pardridge, 1994, J. Pharmacol. Exp. Ther., 268, 14 Jeffries, 1984, Nature, 312, 162, 10.1038/312162a0 Friden, 1993, Science, 259, 373, 10.1126/science.8420006 Kumagai, 1987, J. Biol. Chem., 262, 15214, 10.1016/S0021-9258(18)48160-4 Letvin, 1986, J. Clin. Invest., 77, 977, 10.1172/JCI112399 Green, 1990, Methods Enzymol., 184, 51, 10.1016/0076-6879(90)84259-J Bickel, 1993, 90, 2618 Bickel, 1994, Bioconjugate Chem., 5, 119, 10.1021/bc00026a003 Pardridge, 1994, J. Infect. Dis., 169, 55, 10.1093/infdis/169.1.55 Muckerheide, 1987, J. Immunol., 138, 833 Winter, 1991, Nature, 349, 293, 10.1038/349293a0 Pardridge, 1990, J. Pharmacol. Exp. Ther., 255, 893 Pardridge, 1994, Pharmacol. Res., 11, 738, 10.1023/A:1018940732550 Duvernoy, 1983, Brain Res. Bull., 11, 419, 10.1016/0361-9230(83)90116-8 Pardridge, 1993, 395 Bickel, 1993, Adv. Drug Deliv. Rev., 10, 205, 10.1016/0169-409X(93)90048-9